International Journal of Legal Medicine

, Volume 121, Issue 4, pp 245–257 | Cite as

Cardiac arrhythmias and sudden death in infancy: implication for the medicolegal investigation

  • Horst Wedekind
  • Eric Schulze-Bahr
  • Volker Debus
  • Günter Breithardt
  • Bernd Brinkmann
  • Thomas Bajanowski
Review Article

Abstract

Genetically transmitted diseases are an important cause of juvenile sudden cardiac death (SCD). In a considerable proportion of individuals in which a medicolegal investigation is performed, structural heart disease is absent, and the medical examiner fails to discover an adequate cause of death. In such cases, an inherited arrhythmogenic disease should be considered, which manifests with life-threatening ventricular tachycardia or SCD. Molecular diagnosis is progressively becoming an important tool for these questions. Therefore, postmortem genetic testing (“molecular autopsy”) should be considered as a part of the comprehensive medicolegal investigation in SCD cases without apparent structural heart disease. It will have implications not only for the deceased individual but also for living family members in preventing (further) cardiac events by expert counseling, appropriate lifestyle adjustment, and adequate treatment, if available.

Keywords

Sudden death Infants Arrhythmias Genetics Heart disease 

References

  1. 1.
    Driscoll DJ, Edwards WD (1985) Sudden unexpected death in children and adolescents. J Am Coll Cardiol 5(Suppl):118B–121BPubMedCrossRefGoogle Scholar
  2. 2.
    Davies MJ, Thomas A (1984) Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N Engl J Med 310:1137–1140PubMedCrossRefGoogle Scholar
  3. 3.
    Basso C, Frescura C, Corrado D, Muriago M, Angelini A, Daliento L, Thiene G (1995) Congenital heart disease and sudden death in the young. Hum Pathol 26:1065–1072CrossRefPubMedGoogle Scholar
  4. 4.
    Wren C, O’Sullivan JJ, Wright C (2000) Sudden death in children and adolescents. Heart 83:410–413CrossRefPubMedGoogle Scholar
  5. 5.
    Corrado D, Basso C, Thiene G (2001) Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 50:399–408CrossRefPubMedGoogle Scholar
  6. 6.
    Garson A Jr, Dick M II, Fournier A, Gillette PC, Hamilton R, Kugler JD, van Hare GF III, Vetter V, Vick GW III (1993) The long QT syndrome in children. An international study of 287 patients. Circulation 87:1866–1872PubMedGoogle Scholar
  7. 7.
    Weintraub RG, Gow RM, Wilkinson JL (1990) The congenital long-QT syndromes in childhood. J Am Coll Cardiol 16:674–680PubMedCrossRefGoogle Scholar
  8. 8.
    Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ (1998) Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 339:960–965CrossRefPubMedGoogle Scholar
  9. 9.
    Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R (2001) Genotype–phenotype correlation in the long-QT syndrome. Circulation 103:89–95PubMedGoogle Scholar
  10. 10.
    Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT (1995) A molecular basis for cardiac arrhythmias: HERG mutations cause long QT syndrome. Cell 80:795–803CrossRefPubMedGoogle Scholar
  11. 11.
    Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, Van Raay TJ, Shen J, Towbin JA, Mon AJ, Atkinson DL, Lander GM, Conners TD, Keating MT (1996) Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12:17–23CrossRefPubMedGoogle Scholar
  12. 12.
    Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, Goldstein SAN (1999) MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97:175–187CrossRefPubMedGoogle Scholar
  13. 13.
    Schulze-Bahr E, Wang Q, Wedekind H, Haverkamp W, Chen Q, Sun Y, Rubie C, Hördt M, Towbin JA, Borggrefe M, Assmann G, Qu X, Somberg JC, Breithardt G, Oberti C, Funke H (1997) KCNE1 mutations cause Jervell and Lange–Nielsen syndrome. Nat Genet 17:267–268PubMedCrossRefGoogle Scholar
  14. 14.
    Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, Bendahhou S, Kwiecinski H, Fidzianska A, Plaster N, Fu YH, Ptacek LJ, Tawil R (2002) Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 110:381–388CrossRefPubMedGoogle Scholar
  15. 15.
    Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT (1995) SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80:805–811CrossRefPubMedGoogle Scholar
  16. 16.
    Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosin S, duBell WH et al (2003) Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421:634–639CrossRefPubMedGoogle Scholar
  17. 17.
    Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, Sanguinetti MC, Keating MT (2005) Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A 102:8089–8096CrossRefPubMedGoogle Scholar
  18. 18.
    Zareba W, Moss AJ, Robinson JL, Andrews ML, for the International LQTS Research Group (2001) Clinical course of LQTS in children. PACE 24(Suppl):571 (abstract)Google Scholar
  19. 19.
    Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ (1998) Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 339:960–965CrossRefPubMedGoogle Scholar
  20. 20.
    Zareba W, Moss AJ, Robinson JL, Andrews ML, for the International LQTS Research Group (2001) Influence of genotype on clinical course of LQTS children. PACE 24(Suppl):571 (abstract)Google Scholar
  21. 21.
    Schulze-Bahr E, Fenge H, Etzrodt D, Haverkamp W, Mönnig G, Wedekind H, Breithardt G, Kehl HG (2004) Long QT syndrome and life threatening arrhythmia in a newborn: molecular diagnosis and treatment response. Heart 90:13–16CrossRefPubMedGoogle Scholar
  22. 22.
    Wedekind H, Smits JP, Schulze-Bahr E, Arnold R, Veldkamp MW, Bajanowski T, Borggrefe M, Brinkmann B, Warnecke I, Funke H, Bhuiyan ZA, Wilde AA, Breithardt G, Haverkamp W (2001) De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation 104:1158–1164PubMedCrossRefGoogle Scholar
  23. 23.
    Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348:1866–1874CrossRefPubMedGoogle Scholar
  24. 24.
    Chiang CE, Roden D (2000) The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol 36:1–12CrossRefPubMedGoogle Scholar
  25. 25.
    Southall DP (1983) Identification of infants destined to die unexpectedly during infancy: evaluation of predictive importance of prolonged apnoea and disorders of cardiac rhythm or conduction. Br Med J 286:1092–1096CrossRefGoogle Scholar
  26. 26.
    Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, Grancini F, Marni ED, Perticone F, Rosti D, Salice P (1998) Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 338:1709–1714CrossRefPubMedGoogle Scholar
  27. 27.
    Schwartz PJ, Priori SG, Dumaine R, Napolitano C, Antzelevitch C, Stramba-Badiale M, Richard TA, Berti MR, Bloise R (2000) A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med 343:262–267CrossRefPubMedGoogle Scholar
  28. 28.
    Ackerman MJ, Siu BL, Sturner WQ, Tester DJ, Valdivia CR, Makielski JC, Towbin JA (2001) Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 286:2264–2269CrossRefPubMedGoogle Scholar
  29. 29.
    Tester DJ, Ackerman MJ (2005) Sudden infant death syndrome: How significant are the cardiac channelopathies? Cardiovasc Res (in press)Google Scholar
  30. 30.
    Wedekind H, Bajanowski T, Friederich P, Breithardt G, Wülfing T, Siebrands C, Engeland B, Mönnig G, Haverkamp W, Brinkmann B, Schulze-Bahr E (2005) Sudden infant death syndrome and long QT syndrome: an epidemiological and genetic study. Int J Legal Med (in press)Google Scholar
  31. 31.
    Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Riccardi R, Grossi S, Richiardi E, Borggrefe M (2003) Short QT syndrome: a familial cause of sudden death. Circulation 108:965–970CrossRefPubMedGoogle Scholar
  32. 32.
    Priori SG, Pandit SV, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A, Napolitano C, Anumonwo J, di Barletta MR, Gudapakkam S, Bosi G, Stramba-Badiale M, Jalife J (2005) A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 96:800–807CrossRefPubMedGoogle Scholar
  33. 33.
    Bellocq C, van Ginneken AC, Bezzina CR, Alders M, Escande D, Mannens MM, Baro I, Wilde AA (2004) Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109:2394–2397CrossRefPubMedGoogle Scholar
  34. 34.
    Brugada P, Brugada J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 20:1391–1396PubMedCrossRefGoogle Scholar
  35. 35.
    Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Brignole M, Giordano U, Giovannini T, Menozzi C, Bloise R, Crotti L, Terreni L, Schwartz PJ (2000) Clinical and genetic heterogeneity of right bundle branch block and ST segment elevation syndrome. Circulation 102:2509–2515PubMedGoogle Scholar
  36. 36.
    Brugada J, Brugada R, Brugada P (1998) Right bundle brunch block and ST segment elevation in leads V1–V3: a marker for sudden death in patients with no demonstrable structural heart disease. Circulation 97:457–460PubMedGoogle Scholar
  37. 37.
    Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz-Lopez R, Wang Z, Antzelevitch C, O’Brien RE, Schulze-Bahr E, Keating MT, Towbin JA, Wang Q (1998) Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392:293–296CrossRefPubMedGoogle Scholar
  38. 38.
    Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman BR (1999) The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 33:5–15CrossRefPubMedGoogle Scholar
  39. 39.
    Nademanee K, Veerakul G, Immannit S, Chaowakul V, Bhuripanyo K, Likittanasombat K, Tunsanga K, Kuasirikul S, Malasit P, Tansupasawadikul S, Tatsanavivat P (1997) Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 96:2277–2285Google Scholar
  40. 40.
    Brugada J, Brugada P, Brugada R (1999) The syndrome of right bundle branch block, ST segment elevation in V1 to V3 and sudden death. Are asymptomatic patients at high risk for sudden death? In: Raviele A (ed) Cardiac arrhythmias. Springer, Berlin Heidelberg New York, pp 255–261Google Scholar
  41. 41.
    Oe H, Takagi M, Tanaka A, Namba M, Nishibori Y, Nishida Y, Kawarabayashi T, Yoshiyama M, Nishimoto M, Tanaka K, Yoshikawa J (2005) Prevalence and clinical course of the juveniles with Brugada-type ECG in Japanese population. Pacing Clin Electrophysiol 28:549–554CrossRefPubMedGoogle Scholar
  42. 42.
    Priori SG, Napolitano C, Giordano U, Collisani G, Memmi M (2000) Brugada syndrome and sudden cardiac death in children. Lancet 355:808–809CrossRefPubMedGoogle Scholar
  43. 43.
    Todd SJ, Campbell MJ, Roden DM, Kannankeril PJ (2005) Novel Brugada SCN5A mutation causing sudden death in children. Heart Rhythm 2(5):540–543CrossRefPubMedGoogle Scholar
  44. 44.
    Coumel P, Fidelle J, Lucet V, Attuel P, Bouvrain Y (1978) Catecholaminergic-induced severe ventricular arrhythmias with Adams–Stokes syndrome in children: report of four cases. Br Heart J 40(Suppl):28–37Google Scholar
  45. 45.
    Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P (1995) Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 91:1512–1519PubMedGoogle Scholar
  46. 46.
    Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A (2002). Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106:69–74CrossRefPubMedGoogle Scholar
  47. 47.
    Fisher JD, Krikler D, Hallidie-Smith KA (1999) Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise—pharmacologic testing. J Am Coll Cardiol 34:2015–2022CrossRefPubMedGoogle Scholar
  48. 48.
    Swan H, Piippo K, Viitasalo M, Heikkila P, Paavonen T, Kainulainen K, Kere J, Keto P, Kontula K, Toivonen L (1999) Arrhythmic disorder mapped to chromosome 1q42–q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 34:2035–2042CrossRefPubMedGoogle Scholar
  49. 49.
    Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ (2004) Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner’s cases. Mayo Clin Proc 79:1380–1384PubMedCrossRefGoogle Scholar
  50. 50.
    Denjoy I, Postma A, Lupoglazoff JM, Vaksman G, Kamblock J, Leenhardt A, Wilde AA, Guicheney P (2005) Catecholinergic ventricular tachycardia in children. Arch Mal Coeur Vaiss 98:506–512PubMedGoogle Scholar
  51. 51.
    Lahat H, Eldar M, Levy-Nissenbaum E, Bahan T, Friedman E, Khoury A, Lorber A, Kastner DL, Goldman B, Pras E (2001) Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13–21. Circulation 103:2822–2827PubMedGoogle Scholar
  52. 52.
    Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, Levy-Nissenbaum E, Khoury A, Lorber A, Goldman B, Lancet D, Eldar M (2001) A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 69:1378–1384CrossRefPubMedGoogle Scholar
  53. 53.
    Lerman BB, Dong B, Stein KM, Markowitz SM, Linden J, Catanzaro DF (1998) Right ventricular outflow tract tachycardia due to a somatic cell mutation in G protein subunitalphai2. J Clin Invest 101:2862–2868PubMedCrossRefGoogle Scholar
  54. 54.
    Viskin S, Belhassen B (1990) Idiopathic ventricular fibrillation. Am Heart J 120:661–671CrossRefPubMedGoogle Scholar
  55. 55.
    Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States (1997) Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Circulation 95:265–267Google Scholar
  56. 56.
    Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohmann TE, Graham KJ, Burton DA, Cecchi F (2000) Epidemiology of hypertrophic cardiomyopathy-related death. Circulation 102:858–864PubMedGoogle Scholar
  57. 57.
    Niimura I, Maki T (1989) Sudden cardiac death in childhood. Jpn Circ J 53:1571–1580PubMedGoogle Scholar
  58. 58.
    Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, Graham KJ, Burton DA, Cecchi F (2000) Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 102:858–864PubMedGoogle Scholar
  59. 59.
    Maron BJ (1990) Apical hypertrophic cardiomyopathy: the continuing saga. J Am Coll Cardiol 15(1):91–93PubMedCrossRefGoogle Scholar
  60. 60.
    Arola A, Jokinen E, Ruuskanen O, Saraste M, Pesonen E, Kuusela AL, Tikanoja T, Paavilainen T, Simell O (1997) Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol 146:385–393PubMedGoogle Scholar
  61. 61.
    Kokado H, Shimizu M, Yoshio H, Ino H, Okeie K, Emoto Y, Matsuyama T, Yamaguchi M, Yasuda T, Fujino N, Ito H, Mabuchi H (2000) Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation 102:663–669PubMedGoogle Scholar
  62. 62.
    Arbustini E, Morbini P, Pilotto A, Gavazzi A, Tavazzi L (2000) Familial dilated cardiomyopathy: from clinical presentation to molecular genetics. Eur Heart J 21:1825–1832CrossRefPubMedGoogle Scholar
  63. 63.
    D’Adamo P, Fassone L, Gedeon A (1997) The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet 61:862–867PubMedCrossRefGoogle Scholar
  64. 64.
    Marques JS (1998) Dilated cardiomyopathy caused by plasma membrane carnitine transport defect. J Inherit Metab Dis 21:428–429CrossRefPubMedGoogle Scholar
  65. 65.
    Bonnet D, Martin D, de Lonlay P, Villain E, Jouvet P, Rabier D, Brivet M, Saudubray JM (1999) Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 100:2248–2253PubMedGoogle Scholar
  66. 66.
    Bione S, Maestrini E, Rivella S, Mancini M, Regis S, Romeo G, Toniolo D (1994) Identification of a novel X-linked gene responsible for Emery–Dreifuss muscular dystrophy. Nat Genet 8:323–327CrossRefPubMedGoogle Scholar
  67. 67.
    Thiene G, Nava A, Corrado D, Rossi L, Pennelli N (1988) Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318:129–133PubMedCrossRefGoogle Scholar
  68. 68.
    Nava A, Thiene G, Canciani B, Scognamiglio R, Daliento L, Buja G, Martini B, Stritoni P, Fasoli G (1988) Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol 12:1222–1228PubMedCrossRefGoogle Scholar
  69. 69.
    McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, Norman M, Baboonian C, Jeffery S, McKenna WJ (2000) Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355:2119–2124CrossRefPubMedGoogle Scholar
  70. 70.
    Norgett EE, Hatsell SJ, Carvajal-Huerta L, Cabezas JC, Common J, Purkis PE, Whittock N, Leigh IM, Stevens HP, Kelsell DP (2000) Recessive mutation in desmoplakin disrupts desmoplakin–intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet 9:2761–2766CrossRefPubMedGoogle Scholar
  71. 71.
    Gerull B, Heuser A, Wichter T, Paul M, Basson CT, McDermott DA, Lerman BB, Markowitz SM, Ellinor PT, MacRae CA, Peters S, Grossmann KS, Drenckhahn J, Michely B, Sasse-Klaassen S, Birchmeier W, Dietz R, Breithardt G, Schulze-Bahr E, Thierfelder L (2004) Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 36:1162–1164CrossRefPubMedGoogle Scholar
  72. 72.
    Zardini MC, Lupo P, Titto M, Massacci E, De Ponti R, Storti C, Salerno JA (2001) Arrhythmogenic right ventricular cardiomyopathy: long term follow-up of 80 patients. PACE 24(Suppl):607 (abstract)Google Scholar
  73. 73.
    Dalal D, James C, Tichnell C, Calkins H (2005) Arrhythmogenic right ventricular dysplasia: a United States experience. Heart Rhythm 2(Suppl):115 (abstract)CrossRefPubMedGoogle Scholar
  74. 74.
    Garson A Jr, Gillette PC, McNamara DG (1981) Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr 98:875–882PubMedCrossRefGoogle Scholar
  75. 75.
    Pappone C, Manguso F, Santinelli R, Vicedomini G, Sala S, Paglino G, Mazzone P, Lang CC, Gulletta S, Augello G, Santinelli O, Santinelli V (2004) Radiofrequency ablation in children with asymptomatic Wolff–Parkinson–White syndrome. N Engl J Med 351:1197–1205CrossRefPubMedGoogle Scholar
  76. 76.
    Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS, Ahmad F, Lozado R, Shah G, Fananapazir L, Bachinski LL, Roberts R (2001) Identification of a gene responsible for familial Wolff–Parkinson–White syndrome. N Engl J Med 344:1823–1831CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Horst Wedekind
    • 1
  • Eric Schulze-Bahr
    • 1
  • Volker Debus
    • 2
  • Günter Breithardt
    • 1
  • Bernd Brinkmann
    • 3
  • Thomas Bajanowski
    • 4
  1. 1.Department of Cardiology and AngiologyUniversity of MünsterMünsterGermany
  2. 2.Department of Pediatric CardiologyUniversity of MünsterMünsterGermany
  3. 3.Institute of Legal MedicineUniversity of MünsterMünsterGermany
  4. 4.Institute of Legal MedicineUniversity of Duisburg-EssenEssenGermany

Personalised recommendations